Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alexandre Mebazaa and Frank Ruschitzka.
Alexandre Mebazaa
Connection Strength
1.082
Frank Ruschitzka
  1. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy. Europace. 2017 Nov 01; 19(11):1848-1854.
    View in: PubMed
    Score: 0.185
  2. Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail. 2018 02; 20(2):332-341.
    View in: PubMed
    Score: 0.184
  3. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017 07; 19(7):821-836.
    View in: PubMed
    Score: 0.180
  4. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe. Am J Med. 2021 04; 134(4):482-489.
    View in: PubMed
    Score: 0.057
  5. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Jun; 22(6):941-956.
    View in: PubMed
    Score: 0.056
  6. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019 02; 21(2):137-155.
    View in: PubMed
    Score: 0.050
  7. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. Eur J Heart Fail. 2018 11; 20(11):1591-1600.
    View in: PubMed
    Score: 0.049
  8. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2018 07; 20(7):1081-1099.
    View in: PubMed
    Score: 0.048
  9. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 05; 20(5):853-872.
    View in: PubMed
    Score: 0.047
  10. Indications and practical approach to non-invasive ventilation in acute heart failure. Eur Heart J. 2018 01 01; 39(1):17-25.
    View in: PubMed
    Score: 0.047
  11. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 01; 20(1):16-37.
    View in: PubMed
    Score: 0.046
  12. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017 10; 19(10):1242-1254.
    View in: PubMed
    Score: 0.045
  13. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. N Engl J Med. 2017 05 18; 376(20):1956-1964.
    View in: PubMed
    Score: 0.044
  14. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017 12; 19(12):1574-1585.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.